Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features
Masafumi Seki,1,* Kaori Yabuno,1,2,* Koji Miyawaki,1,2 Yoshihiro Miwa,2 Kazunori Tomono11Division of Infection Control and Prevention, 2Department of Pharmacy, Osaka University Hospital, Suita, Osaka, Japan*These authors contributed equally to this workBackground: A trough concentration of >2...
Saved in:
Main Authors: | Seki M (Author), Yabuno K (Author), Miyawaki K (Author), Miwa Y (Author), Tomono K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
by: Yabuno K, et al.
Published: (2013) -
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir
by: Jessica Cusato, et al.
Published: (2015) -
Model‐informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration‐time curve: A simulation study
by: Kazutaka Oda, et al.
Published: (2023) -
Evaluation of urinary excretion of dolutegravir or emtricitabine/tenofovir/elvitegravir/cobicistat antiretroviral-based regimens using plasma and urine trough concentration
by: Jérémy Lourenco, et al.
Published: (2018) -
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
by: Takashi Ueda, et al.
Published: (2020)